Cargando…

PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma

BACKGROUND: Gastric cancer is associated with tumor microenvironment and chronic inflammation, but the underlying tumor-promoting mechanisms still remain unknown. METHODS: The ATAC-seq was used to identify genes with chromatin accessibilities in promoter regions. The RNA-seq datasets were performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Zhizhan, Huang, Chenshen, Zhao, Hongmei, Zhou, Jinzhe, Hu, Muren, Chen, Qing, Ge, Bujun, Huang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283001/ https://www.ncbi.nlm.nih.gov/pubmed/34277610 http://dx.doi.org/10.3389/fcell.2021.662707

Ejemplares similares

Chromatin Accessibility Regulates Gene Expression and Correlates With Tumor-Infiltrating Immune Cells in Gastric Adenocarcinoma
por: Huang, Chenshen, et al.
Publicado: (2021)

Impact of endoscopic metallic stent placement and emergency surgery on detection of viable circulating tumor cells for acute malignant left-sided colonic obstruction
por: Ni, Zhizhan, et al.
Publicado: (2023)

Propensity score‐matched comparison of stenting as a bridge to surgery and emergency surgery for acute malignant left‐sided colonic obstruction
por: Cao, Yuepeng, et al.
Publicado: (2021)

Novel insight on predicting prognosis of gastric cancer based on inflammation
por: Ni, Zhizhan, et al.
Publicado: (2022)

The olfactory critical period is determined by activity-dependent Sema7A/PlxnC1 signaling within glomeruli
por: Inoue, Nobuko, et al.
Publicado: (2021)

Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus
por: Zeng, Yongji, et al.
Publicado: (2023)

Recanalization in Uncut Roux-en-Y Reconstruction: An Animal Experiment and a Clinical Study
por: Wu, Feng, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction
por: Huang, Chenshen, et al.
Publicado: (2022)

miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4
por: Zhou, Jinzhe, et al.
Publicado: (2017)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
por: Meijing, Zhang, et al.
Publicado: (2022)

Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma
por: Luo, Na, et al.
Publicado: (2022)

Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
por: Lyu, Zejian, et al.
Publicado: (2022)

Tranditional Roux-en-Y vs Uncut Roux-en-Y in Laparoscopic Distal Gastrectomy: a Randomized Controlled Study
por: Xie, Huahao, et al.
Publicado: (2023)

Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic data
por: Huang, Chenshen, et al.
Publicado: (2022)

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis
por: Chang, Zhengyan, et al.
Publicado: (2020)

Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
por: Pan, Jingjing, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability
por: Yang, Dongdong, et al.
Publicado: (2021)

Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy
por: Chen, Ganyi, et al.
Publicado: (2022)

Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma
por: Dong, Bo, et al.
Publicado: (2021)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
por: Xue, Shengbai, et al.
Publicado: (2022)

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
por: Zhou, Hong, et al.
Publicado: (2021)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Sclerosing encapsulating peritonitis as a rare cause of intestinal obstruction after the treatment of peritoneal mesothelioma: a case report and review of the literature
por: Ni, Zhizhan, et al.
Publicado: (2021)

Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells
por: Xi, Yue, et al.
Publicado: (2023)

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
por: Lu, Liting, et al.
Publicado: (2022)

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
por: Zhou, Hong, et al.
Publicado: (2022)

Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data
por: Zou, Qiyuan, et al.
Publicado: (2021)

m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Pan, Junfan, et al.
Publicado: (2021)

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
por: Tong, Ni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c31jsr194ehr3ajvta063ohgd4